Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APIXABAN Cause Hepatic neoplasm? 12 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hepatic neoplasm have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.

12
Reports of Hepatic neoplasm with APIXABAN
0.0%
of all APIXABAN reports
4
Deaths
3
Hospitalizations

How Dangerous Is Hepatic neoplasm From APIXABAN?

Of the 12 reports, 4 (33.3%) resulted in death, 3 (25.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.

Is Hepatic neoplasm Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does APIXABAN Cause?

Death (18,501) Cerebrovascular accident (7,237) Atrial fibrillation (5,690) Off label use (5,590) Thrombosis (5,298) Fall (5,063) Cardiac disorder (4,917) Haemorrhage (4,770) Dyspnoea (4,379) Gastrointestinal haemorrhage (4,030)

What Other Drugs Cause Hepatic neoplasm?

OCTREOTIDE (300) ADALIMUMAB (98) LANREOTIDE (85) EVEROLIMUS (84) AMLODIPINE (74) ROSUVASTATIN (55) IMATINIB (51) BEVACIZUMAB (49) RIBAVIRIN (49) METFORMIN (47)

Which APIXABAN Alternatives Have Lower Hepatic neoplasm Risk?

APIXABAN vs APOMORPHINE APIXABAN vs APRACLONIDINE APIXABAN vs APREMILAST APIXABAN vs APREPITANT APIXABAN vs APROTININ

Related Pages

APIXABAN Full Profile All Hepatic neoplasm Reports All Drugs Causing Hepatic neoplasm APIXABAN Demographics